Header image

Session I: Moving from clinical trials to the real-world

Tracks
Track 1
Track 2
Track 3
.
Thursday, September 12, 2019
9:00 AM - 10:45 AM
Montreal Ballroom, Level 11

Speaker

Agenda Item Image
Dr Sunil Solomon
Associate Professor Of Medicine
Johns Hopkins University School Of Medicine

Overcoming barriers to integrating hepatitis C testing, linkage to care and treatment into existing services: success stories from low and middle income countries 

9:00 AM - 9:20 AM

Speaker Presentation

Video Recording

Biography

Dr. Solomon is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. He is trained in medicine from India and received a MPH and Phd in Epidemiology from the Johns Hopkins University. His research interests include the strategies to improve the HIV and HCV care continue among key populations in low and middle income countries. He was elected into the Phi Beta Kappa honors society and one of the first recipients of the NIDA Avenir award aimed at identifying young researchers who show promise in the field of HIV and substance abuse.
Agenda Item Image
Dr. Lisa R. Metsch
Dean and Professor of Sociomedical Sciences
Columbia University

Moving along the HCV treatment cascade: lessons learned from HIV

9:20 AM - 9:40 AM

Biography

Dr. Metsch, a medical sociologist, is the Dean of the Columbia University School of General Studies and Professor of Sociomedical Sciences at Columbia University’s Mailman School of Public Health. Dr. Metsch’s current research focuses on testing intervention models to address prevention and treatment needs for persons living with and at risk for HIV/HCV and substance use disorders.
Agenda Item Image
Ricardo Baptiste-Leite
UNITE

Skype Presentation: Supporting enhanced efforts to address hepatitis C and health for people who use drugs through strong government leadership

9:40 AM - 10:00 AM

Biography

Member of the Portuguese Parliament (Health and the Foreign Affairs Committees), National Spokesperson for Health of the Social Democratic Party (PSD) and Head of Public Health at Católica University of Portugal. Founding President of ‘UNITE – Global Parliamentarians Network to End HIV/AIDS, viral hepatitis and other infectious diseases’. Vice President of the ‘Parliamentary Network on The World Bank & International Monetary Fund’. One of six people globally nominated by ‘The Economist Intelligence Unit’ (2016) as a ‘HCV Change Maker’ in recognition of leadership in the field of hepatitis c. Guest Lecturer at NOVA Information Management School and NOVA Medical School. Former Deputy Mayor and City Councilor of Cascais responsible for health, economic diplomacy and international relations. Prior to being elected MP, Dr. Baptista Leite worked as a practicing physician, including a 5-year Infectious Diseases residency program at the Western Lisbon Hospital Centre and an internship at the World Health Organization (Copenhagen). PhD candidate at Maastricht University, having completed post-graduate studies in multiple universities including Johns Hopkins University, Harvard Kennedy School of Government and Harvard Medical School. Founder of ‘CREATING HEALTH – Research and Innovation Funding’ and Co-founder of the ‘Estoril Conferences’. Main author of the book ‘Citizenship for Health’, among other publications.
Panel

Questions & Discussion

10:00 AM - 10:15 AM

Biography

Dr Nick Scott
Econometrician
Burnet Institute

AUSTRALIA WILL NEED TO INCREASE TESTING TO ACHIEVE HEPATITIS C ELIMINATION

10:15 AM - 10:30 AM

Abstract

Video Recording

Biography

Dr Nick Scott is an Econometrician at the Burnet Institute. He conducts mathematical and economic modelling studies to generate evidence for the most effective hepatitis C elimination strategies.
Dr. Alison Marshall
Post-doctoral Fellow
The Kirby Institute And The Centre for Social Research In Health

Barriers and facilitators to engaging in HCV management and DAA therapy among general practitioners and drug and alcohol specialists - The practitioner experience

10:30 AM - 10:45 AM

Abstract

Video Recording

Biography

Alison is a post-doctoral fellow at the Kirby Institute, and the Centre for Social Research in Health, UNSW Sydney, Australia. Her primary research focus is on hepatitis C virus and drug use with particular attention to reducing barriers to care for people who inject drugs.

Chair

Gregory Dore
Head, Viral Hepatitis Clinical Research Program
The Kirby Institute, UNSW Sydney

Agenda Item Image
Shruti Mehta
Professor
Johns Hopkins University

loading